Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tiziana Life Sciences Ltd (NQ: TLSA )

0.9750 -0.2050 (-17.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tiziana Life Sciences Ltd

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building
Consumer support for robotaxis is low for people who have not been inside a self-driving vehicle or live in a city where the vehicles operate. 
Via Benzinga
The 3 Best EV Stocks to Buy in August 2024
The best EV stocks may face an uphill battle, but their share prices seem too depressed after the latest plunge. 
Via InvestorPlace
Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding
Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding 
Via News Direct
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
EXCLUSIVE: Top Tesla Options Trades Recommended By Trading Expert
Trading expert Anne-Marie Baiynd shared option trade ideas for Tesla on Benzinga's YouTube, discussing potential positive catalysts and bullish strategies. 
Via Benzinga
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
7 Battered Blue-Chip Stocks to Bounce From Your Portfolio This Spring
Not all big companies are doing well in the stock market. For various reasons, these battered blue-chip stocks are struggling mightily. 
Via InvestorPlace
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
3 EV Stocks to Buy on the Dip: March 2024
The electric vehicle market slump has significantly impacted many EV stocks to buy - But the slump will not last forever. 
Via InvestorPlace
Topics Electric Vehicles
Exposures Electric Vehicles
3 EV Stocks to Buy for the Next Bull Run: March 2024
EV stocks have broadly underperformed the market in 2024, which has, in turn, created a number of opportunities to buy at a bargain. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
7 Over-Hyped Stocks to Sell Before They Plunge
It wasn't too long ago that these stocks were considered hot commodities. But now they're just overhyped stocks to sell. 
Via InvestorPlace
Tesla Shares Hardly Damaged Despite Recall: Full Self-Driving Is Elon Musk's 'Holy Grail,' Analyst Says
Tesla shares fell only slightly. And auto recalls are nothing new. Recall how, in 1981, Ford issued a recall on 21 million vehicles. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Don't Get Caught In Equity Rally Hype: Lessons From 2023 To Remember In 2024
After a volatile 2023, equity markets appear to be rallying into 2024. Can they keep it up? 
Via Benzinga
Tiziana Expects To Start Enrolling Patients in Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using its Novel Intranasal Monoclonal Antibody Foralumab
--News Direct-- 
Via News Direct
Tiziana Expects To Start Enrolling Patients In Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using Its Novel Intranasal Monoclonal Antibody Foralumab
This month, Tiziana Life Sciences (NASDAQ: TLSA) expects to start enrolling patients for a phase 2a trial of Foralumab, an immunomodulation therapy for Secondary Progressive Multiple Sclerosis (SPMS)... 
Via Benzinga
SPDR ETF Report For Tuesday, November 21
Via Talk Markets
Topics ETFs
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic worth checking out on Wednesday and we have all the latest news happening this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Tiziana Life Sciences reveals "exciting" clinical data from latest MS trial
--News Direct-- 
Via News Direct
Tiziana Life Sciences reports six-month PET scan results for MS patients
--News Direct-- 
Via News Direct
Tiziana to Announce Six-Month Human Safety and Biomarker Data at the ECTRIMS Annual Congress, Following-Up from Positive Outcomes Data Presented in June
--News Direct-- 
Via News Direct
Exposures Product Safety
Tiziana To Announce Six-Month Human Safety And Biomarker Data At The ECTRIMS Annual Congress, Following-Up From Positive Outcomes Data Presented In June
Tiziana (NASDAQ: TLSA) is following up with anticipated human data and announced the acceptance of a late-breaking poster at the 39th Congress of the Europea 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.